Cart summary

You have no items in your shopping cart.

Ipafricept Antibody

SKU: orb1980408

Description

Ipafricept (OMP-54F28) is a Wnt pathway inhibitor composed of a human frizzled-8 receptor decoy fused to an IgG1 Fc fragment. It acts by sequestering Wnt ligands, demonstrating antitumor activity in preclinical studies of solid tumors, including in vivo models of ovarian and pancreatic cancers.

Research Area

Signal Transduction, Stem Cell & Developmental Biology

Images & Validation

Key Properties

CAS Number1391727-24-4
MW41.12 kDa
Purity99.2% (SDS-PAGE); 97.4% (SEC-HPLC)
TargetWnt/beta-catenin

Bioactivity

In Vivo
Ipafricept administered intraperitoneally at a dose of 10 mg/kg per week or 25 mg/kg every 2 weeks for 42 days in combination with Gemcitabine (50 mg/kg per week or 5 mg/kg per week) and Nab-paclitaxel (10 mg/kg per week) significantly enhanced tumor growth inhibition. In a mouse model of ovarian cancer xenografts, Ipafricept administered intraperitoneally at a dose of 45 mg/kg every 2 weeks for 42 days, in combination with Nab-paclitaxel (7.5 mg/kg/week), demonstrated enhanced anti-tumor activity over Carboplatin (30 mg/kg/week). In a mouse model of total skin injury, Ipafricept administered subcutaneously at a dose of 10 mg/kg on days 0 and 3 was able to compete with RL-QN15 for binding and reduce the interaction of RL-QN15 with FZD8, thereby counteracting its activation of the Wnt/β-catenin signaling pathway.
In Vitro
Ipafricept inhibited the proliferative and migratory effects of the peptide RL-QN15 on human embryonic stem cells (hESCs) after treatment with 10 μg/mL for 4 hours. When Ipafricept was treated with 10 μg/mL for 0-48 hours, it reversed the RL-QN15-induced activation of the Wnt/β-catenin signaling pathway, which in turn reversed the effects of RL-QN15 on the proliferation, migration and stemness of hESCs.

Storage & Handling

StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

OMP54F28, OMP-54F28, FZD8Fc, FZD8-Fc, bcatenin, betacatenin, beta-catenin, Wnt, Wnt/b-catenin, Wnt/betacatenin, Wnt/β-catenin, βcatenin

Similar Products

  • Ipafricept Monoclonal Antibody [orb2977317]

    ELISA,  FA,  In vivo

    Human

    Mammal

    Monoclonal

    Unconjugated

    100 μg, 1 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Ipafricept Antibody (orb1980408)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 560.00
5 mg
$ 1,370.00
10 mg
$ 2,170.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry